| |
| |
|
| Insider
Information: |
Williams Lewis T |
| Relationship: |
Director |
| City: |
Brea |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
455,336 |
|
|
Indirect Shares
|
2,095,114 |
|
|
| Direct
Value |
$17,302,768 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,550,450 |
|
|
| Total
Value |
$17,302,768 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Beckman Coulter Inc |
BEC |
Director |
2011-06-30 |
0 |
2009-11-02 |
0 |
Premium* |
|
|
Five Prime Therapeutics Inc |
FPRX |
Director |
2019-09-01 |
455,336 |
|
0 |
Premium* |
|
|
Arcellx, Inc. |
ACLX |
Director |
2022-02-08 |
0 |
2022-02-08 |
2,095,114 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACLX |
Arcellx, Inc. |
Director |
– • – |
2022-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
2,095,114 |
2,095,114 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Director |
– • – |
2019-09-01 |
4 |
D |
$5.43 |
$38,140 |
D/D |
(7,024) |
455,336 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Director |
– • – |
2019-02-26 |
4 |
D |
$11.95 |
$11,066 |
D/D |
(926) |
461,360 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Director |
– • – |
2019-02-25 |
4/A |
A |
$0.00 |
$0 |
D/D |
1,000 |
462,360 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Director |
– • – |
2019-02-05 |
4 |
D |
$11.43 |
$35,936 |
D/D |
(3,144) |
462,286 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Chairman |
• • – |
2018-11-05 |
4 |
OE |
$4.56 |
$415,950 |
D/D |
91,217 |
465,430 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Chairman |
• • – |
2018-09-01 |
4 |
D |
$14.00 |
$98,336 |
D/D |
(7,024) |
374,213 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Chairman |
• • – |
2018-02-05 |
4 |
D |
$18.42 |
$57,784 |
D/D |
(3,137) |
376,237 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2017-09-01 |
4 |
D |
$34.34 |
$268,779 |
D/D |
(7,827) |
381,958 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2017-03-01 |
4 |
D |
$44.77 |
$1,545,998 |
D/D |
(34,532) |
388,754 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2017-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
16,875 |
423,286 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2017-01-03 |
4 |
D |
$48.60 |
$246,159 |
D/D |
(5,065) |
428,827 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-12-23 |
4 |
OE |
$4.56 |
$166,103 |
D/D |
30,000 |
463,892 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-12-23 |
4 |
AS |
$50.49 |
$1,514,859 |
D/D |
(30,000) |
433,892 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-09-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
407 |
433,892 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-09-01 |
4 |
D |
$44.74 |
$340,606 |
D/D |
(7,613) |
456,715 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-09-01 |
4 |
GD |
$44.74 |
$1,002,892 |
D/D |
22,416 |
434,299 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-09-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
22,416 |
406,411 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Chairman |
• • – |
2016-09-01 |
4/A |
D |
$44.74 |
$1,459,106 |
D/D |
(32,613) |
431,715 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Chairman |
• • – |
2016-09-01 |
4/A |
GD |
$0.00 |
$0 |
D/D |
22,416 |
409,299 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
Executive Chairman |
• • – |
2016-09-01 |
4/A |
GD |
$0.00 |
$0 |
D/D |
0 |
428,827 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
42,500 |
464,328 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-05-06 |
4 |
OE |
$1.23 |
$99,999 |
D/D |
81,300 |
421,828 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-04-21 |
4 |
AS |
$48.05 |
$2,312,214 |
D/D |
(48,121) |
340,528 |
0 |
- |
|
| FPRX |
Five Prime Therapeutics I... |
President, CEO and Chairman |
• • – |
2016-04-21 |
4 |
OE |
$8.49 |
$408,547 |
D/D |
48,121 |
388,649 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
